TORONTO/OTTAWA (Reuters) - Deliveries of AstraZeneca Plc's COVID-19 vaccine to Canada could begin before the end of March, if the country's health regulator approves its use, federal procurement minister Anita Anand said on Thursday.
AstraZeneca Canada filed a rolling application for its vaccine with Health Canada in October and is waiting for approval from the drug regulator. Health Canada is expected to complete its review soon.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!